Progressing Drug Therapies to Market: The Criticality of Analytical Testing Robustness

November 30th 10am ET | 3pm GMT | 7am PT

Register now

Ensure a smooth development progression with the right analytical testing support.

Rigorous, effective analytical testing is key in the drug development lifecycle. Because this testing is used to verify control of drug chemistry, it can help identify barriers that prevent movement to the next phase in the development process. That’s why it’s critical to have efficient, accurate and high-quality analytical support for your testing requirements.

Partnering with the right CDMO can mean the difference between quality results and potential setbacks for your program. Join this webinar to hear Cambrex experts discuss:

  • Early-phase analytical support for IND submission.
  • Transitioning methods from early-phase to late-phase.
  • Case studies highlighting how Cambrex applies analytical testing expertise to help progress clients’ drug therapies.

Complete the form to register

Register now

Meet the Speakers

Tracy Milburn

Director, Analytical Services at Cambrex

Daniel Kirschner

Executive Director, Analytical and Biopharmaceutical Services at Cambrex

Register now to secure your spot!

Our presenter will carry out a live Q&A, if you have any questions please let us know.

By completing this form you agree Cambrex and Citeline may contact you directly about industry news, products, services and events that may be of interest. This is subject to and Cambrex's privacy policy and Citeline's privacy policy
Pharma Ignite Inspire. Connect. Innovate.
Powered by

Copyright ©️ 2023 Pharma Intelligence UK Limited (Citeline), a Norstella company. Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.